Popular weight-loss drugs Ozempic and Wegovy may slow biological aging By calming inflammation and reducing excess fat, semaglutide may postpone several molecular signs of aging, pointing to the potential of GLP1 receptor agonists to help prevent agerelated diseases Date: July 14, 2026 Source: University of California - San Diego Summary: Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging
Report any suspected side effects from supplements or medications via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
This article is structured to guide you from the basic science of why injections hurt to advanced tips for minimizing discomfort, ensuring you have the tools to make every dose a positive step forward
Foundational Nutritional Support: Multi Complete Reduced calorie intake can often lead to lower micronutrient intake
In 2020, Ro switched to obesity management and, after Wegovy was approved by the Food and Drug Adminstration the following year, Reitano said patient inquiries started pouring in by the "tens of thousands." Now, Ro is shoveling marketing dollars into its GLP-1 program from digital ads, TV commercials and posters lining subway stations, to influencer campaigns featuring patients such as Beard
can we discuss what this means for my dose?" This collaborative approach is the hallmark of the Blue Horizon Method
